Iimura, S.; Nose, Y.; Tabata, K.; Oda, K.; Yamashita, Y.; Takahashi, N.; Kawano, Y.
Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study. Toxins 2023, 15, 553.
https://doi.org/10.3390/toxins15090553
AMA Style
Iimura S, Nose Y, Tabata K, Oda K, Yamashita Y, Takahashi N, Kawano Y.
Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study. Toxins. 2023; 15(9):553.
https://doi.org/10.3390/toxins15090553
Chicago/Turabian Style
Iimura, Shigeomi, Yasuyo Nose, Keiko Tabata, Kenji Oda, Yoshiyuki Yamashita, Naohiro Takahashi, and Yoshiaki Kawano.
2023. "Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study" Toxins 15, no. 9: 553.
https://doi.org/10.3390/toxins15090553
APA Style
Iimura, S., Nose, Y., Tabata, K., Oda, K., Yamashita, Y., Takahashi, N., & Kawano, Y.
(2023). Safety and Effectiveness of OnabotulinumtoxinA in Patients with Laryngeal Dystonia: Final Report of a 52-Week, Multicenter Postmarketing Surveillance Study. Toxins, 15(9), 553.
https://doi.org/10.3390/toxins15090553
